1h Free Analyst Time
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Topical Scar Treatment Market Report Speak directly to the analyst to clarify any post sales queries you may have.
The topical scar treatment market by revenue is expected to grow at a CAGR of 4.58% during the period 2022-2027.
MARKET INSIGHTS
In topical scar treatment, Keloid scars are more common in Asian, African, and UK countries that highly demand the treatments. The increasing number of burn injuries in those regions drives the market growth. Burn injuries are the major factor that causes scar contracture, which drives the demand for scar treatments. Topical scar treatment products such as gel and silicone scar sheets are the best product solutions that reduce scar appearance. Changing the preference of people from offline to online shopping has positively impacted the sale of topical scar treatment products by the e-commerce platform, thereby boosting the market growth.
The following factors are likely to contribute to the growth of the topical scar treatment market:
- Changing concern about better face/ skin appearance
- Increasing cases of keloids scars & scars appearance induced injuries
- Increasing the use of OTC scar treatment products for home use
- Increasing Prevalence of Burn Injuries and Rising Demand for Burn Scar Treatments
- High demand for Acne Scar Removal by Teenager & Adult Age Group
- Increasing Number of Surgical Procedures & Accidental Cases
- High Demand for Silicone-Based Products for Scar’s Treatments
The report considers the present scenario of the topical scar treatment market and its market dynamics for the period 2022-2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.
TOPICAL SCAR TREATMENT MARKET SEGMENTATION
This research report includes a detailed segmentation by:
- Scar Type
- Form
- Distribution Channels
- Geography
SEGMENTATION ANALYSIS
- The acne scar type segment accounted for around 34% of the market share in the global topical scar treatment market and with a growth rate of around 5% CAGR during the forecast period. The high prevalence of acne in adults and teens leaves a scar appearance, which influences the demand for topical scar treatment products in the market
- The increasing adult and teenage population and rising pollution induced acne's appearance on the human face, leading to the atrophic scar’s appearance. Thereby, the increasing prevalence of raised scars derives the demand for acne scars topical treatment products in the market
Market Segmentation by Scar Type
- Keloids Scars and Hypertrophic Scars
- Acne Scars
- Contracture Scars
Market Segmentation by Form
- Gel
- Scar Sheets
- Others
Market Segmentation by Distribution Channels
- Hospital and Retail Pharmacies
- Online Sales Channel
- Other Distribution Channels
- Supermarket and Hypermarket
- Wellness Centers
GEOGRAPHICAL ANALYSIS
- North America is one of the leading countries by economy and healthcare concern that drives the application of rate of topical scar treatment products. On the other hand, several manufacturers are available in the region, which will boost the market growth
- According to Global Times, around 15 million licensed procedures of plastic surgeries were done in China in 2017 and approximately 20 million in 2018. The increasing number of cosmetic surgeries leave a scar appearance. Even the smaller scar appearance on facial surfaces drives the demand for scar reduction treatments to better the market growth
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- APAC
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa
- Turkey
- South Africa
- Saudi Arabia
VENDOR ANALYSIS
- Perrigo acquired two scar treatment product manufacturers such as Tracxn and HRA Pharma. HRA pharma brand product Mederma is one of the leading products in the topical scar treatment market, and it is highly suggested by dermatologists. Mederma is one of the high-sale products for scar treatment in the international market
Prominent Vendors
- Perrigo Company Plc
- HRA Pharma
- Molnlycke Healthcare AB
- Newmedical Technology
- Alliance Pharma
- Smith+Nephew
Other Prominent Vendors
- Aroamas LLC
- Biodermis
- Implus (Spenco)
- Genomma Lab Internacional
- Revitol Corporation
- Eucare Pharmaceuticals
- Galderma
- Integra LifeSciences
- Johnson & Johnson
- Loreal
- Mylan N.V
- Murud Inc
- Oculus Innovative Sciences Inc
- Pharmaxis Ltd
- Rejuvaskin
- Re’equil
- Sientra
- SkinKraft
- The Menarini Group
- Terez & Honor
- Promore Pharma
KEY QUESTIONS ANSWERED:
1. How big is the topical scar treatment market?
2. Which region holds the highest share in the topical scar treatment market?
3. Who are the key players in the topical scar treatment market?
4. What are the major factors driving the growth of the topical scar treatment market?
5. What are the key trends in the topical scar treatment market?
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market at a Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Growth Restraints
11 Market Landscape
12 Scar Type
13 Form
14 Distribution Channel
15 Geography
16 North America
17 Europe
18 APAC
19 Latin America
20 Middle East & Africa
21 Competitive Landscape
22 Key Company Profiles
23 Other Prominent Vendors
24 Report Summary
25 Quantitative Summary
26 Appendix
List of Exhibits
List of Tables
Companies Mentioned
- Perrigo Company Plc
- HRA Pharma
- Molnlycke Healthcare AB
- Newmedical Technology
- Alliance Pharma
- Smith+Nephew
- Aroamas LLC
- Biodermis
- Implus (Spenco)
- Genomma Lab Internacional
- Revitol Corporation
- Eucare Pharmaceuticals
- Galderma
- Integra LifeSciences
- Johnson & Johnson
- Loreal
- Mylan N.V.
- Murud Inc
- Oculus Innovative Sciences Inc.
- Pharmaxis Ltd
- Rejuvaskin
- Re’equil
- Sientra
- SkinKraft
- The Menarini Group
- Terez & Honor
- Promore Pharma
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 249 |
| Published | February 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 166.98 Million |
| Forecasted Market Value ( USD | $ 218.5 Million |
| Compound Annual Growth Rate | 4.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
